Needle-Free Injection System Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021
The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period. Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection system over the conventional needle injection may hinder the growth of this market during the forecast period. The report segments the market based on product, technology, type, site of delivery, applications, end user and regions. Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.
North America is expected to dominate the market in 2016, with the U.S. accounting for a major share. However, Europe is expected to grow at the highest CAGR during the forecast period. The high growth in this market is attributed to the rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving the market growth in Europe.
The needle-free injection system market is fragmented with several global as well as local players. Players in this market offer several detectors across different subsegments of this market. Key players in this market include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).
Target Audience:
- Needle-free Injection Manufacturers
- Needle-free Injection Instrument Manufacturers and Suppliers
- Research and Development Companies
- Medical Research Laboratories
- Academics Medical Centers and Universities
- Research and Consulting Firms
To know about the assumptions considered for the study, download the pdf brochure
Scope of the Report
This report categorizes the needle-free injection system market into the following segments and sub segments.
Global Needle Free Injection System Market, By Product
- Fillable Needle-Free Injectors
- Prefilled Needle-Free Injectors
Global Needle Free Injection System Market, By Technology
- Jet-Based Needle-Free Injectors
- Spring-Based Needle-Free Injectors
- Laser-Powered Needle-Free Injectors
- Vibration-Based Needle-Free Injectors
Global Needle Free Injection System Market, By Usability
- Reusable Needle-Free Injectors
- Disposable Needle-Free Injectors
Global Needle Free Injection System Market, by type of Medication
- Liquid-based needle free injectors
- Powder-based needle free injectors
- Projectile/depot-based needle free injectors
Global Needle Free Injection System Market, by Site of Delivery
- Intra dermal injectors
- Intramuscular injectors
- Subcutaneous injectors
Global Needle Free Injection System Market, by Application
- Vaccine Needle free delivery
- Insulin Needle free delivery
- Pain Management Needle free delivery
- Oncology Needle free delivery
- Others applications
Global Needle-Free Injection System Market, by End User
- Hospitals and Clinics
- Homecare Settings
- Research Laboratories
- Pharmaceutical and Biotechnology companies
- Other End Users
Global Needle Free Injection System Market, by Region
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Rest of the Europe (RoE)
- Asia
- Japan
- China
- India
- RoA
- Rest of the World (RoW)
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to 5).
Further Split of the RoW Needle-free Injection System Market
Needle-free injection system market size and growth rate estimates of Latin America, Pacific, and Middle East & Africa.
Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.
Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.
Based on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016. The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.
Based on the end user, the market is segmented into Hospitals and Clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies and other end user. The hospitals and clinics segment is expected to grow at the highest rate in the forecast period. The growth in this segment can primarily be attributed to the advancement in the medication or drug delivery technology and rising geriatric population.
Based on the type, the market is segmented into Liquid-based, projectile-based, powder-based needle-free injectors. The liquid-based needle-free injectors segment is projected to be the fastest-growing segment during forecast period in 2016. The advantages of this mode of delivery have drawn the attention of a number of market players.
The market is dominated by North America, followed by Europe, Asia, and the Rest of the World. While North America is expected to dominate the market in 2016, Europe is expected to grow at the highest CAGR during the forecast period. The high growth in this market is attributed to the rising demand for biologics, growing prevalence of chronic diseases, technological advancements, mergers and acquisitions by major companies in the market, favorable reimbursement policies, increasing healthcare expenditure and regulatory approvals of new injection system are key factors driving the market growth in Europe
Key players in the market include Antares Pharma, Inc. (U.S.), Endo International plc (U.S.), PharmaJet (U.S), Bioject Medical Technologies Inc. (U.S), Medical International Technology, Inc. (U.S), INJEX Pharma AG (Germany), National Medical Products Inc. (U.S.), Valeritas, Inc. (U.S.), European Pharma Group (Netherland), PenJet Corporation (U.S), Crossject SA (France).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitation
1.6 Stakeholders
2 Research Methodology (Page No. - 20)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study
3 Executive Summary (Page No. - 27)
3.1 Introduction
3.2 Conclusion
4 Premium Insights (Page No. - 33)
4.1 Market Overview
4.2 Market, By Type
4.3 Market, By Technology and Region
4.4 Market, By End User
4.5 Geographic Snapshot of the Market
5 Market Overview (Page No. - 38)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Prevalence of Chronic Diseases
5.2.1.2 Increasing Incidence of Communicable Diseases Due to Needlestick Injuries
5.2.1.3 Rise in Demand for Self-Injection Devices
5.2.2 Market Restraints
5.2.2.1 Higher Cost of Development as Compared to Conventional Injection System
5.2.3 Market Opportunities
5.2.3.1 Rising Demand for Biosimilars and Vaccination
5.2.3.2 Emerging Markets
5.2.4 Market Challenges
5.2.4.1 Need to Ensure System Sterility
5.2.4.2 Alternative Modes of Drug Delivery
5.3 Regulatory Scenario in the U.S.
5.3.1 Fda Approval
6 Needle-Free Injection System Market, By Product (Page No. - 47)
6.1 Introduction
6.2 Fillable Needle-Free Injectors
6.3 Prefilled Needle-Free Injectors
7 Needle-Free Injection System Market, By Technology (Page No. - 51)
7.1 Introduction
7.2 Jet-Based Needle-Free Injectors
7.3 Spring-Based Needle-Free Injectors
7.4 Laser-Powered Needle-Free Injectors
7.5 Vibration-Based Needle-Free Injectors
8 Needle-Free Injection System Market, By Type (Page No. - 57)
8.1 Introduction
8.2 Liquid-Based Needle-Free Injectors
8.3 Projectile/Depot-Based Needle-Free Injectors
8.4 Powder-Based Needle Free Injectors
9 Needle-Free Injection System Market, By Usability (Page No. - 61)
9.1 Introduction
9.2 Disposable Needle-Free Injectors
9.3 Reusable Needle-Free Injectors
10 Needle-Free Injection System Market, By Site of Delivery (Page No. - 65)
10.1 Introduction
10.2 Subcutaneous Injectors
10.3 Intramuscular Injectors
10.4 Intradermal Injectors
11 Needle-Free Injection System Market, By Application (Page No. - 70)
11.1 Introduction
11.2 Vaccine Delivery
11.3 Insulin Delivery
11.4 Oncology
11.5 Pain Management
11.6 Other Applications
12 Needle-Free Injection System Market, By End User (Page No. - 77)
12.1 Introduction
12.2 Hospitals and Clinics
12.3 Home Care Settings
12.4 Research Laboratories
12.5 Pharmaceutical and Biotechnological Companies
12.6 Other End Users
13 Needle-Free Injection System Market, By Region (Page No. - 84)
13.1 Introduction
13.2 North America
13.2.1 U.S.
13.2.2 Canada
13.3 Europe
13.3.1 Germany
13.3.2 France
13.3.3 U.K.
13.3.4 Italy
13.3.5 Spain
13.3.6 Rest of the Europe (RoE)
13.4 Asia
13.4.1 Japan
13.4.2 China
13.4.3 India
13.4.4 Rest of Asia (RoA)
13.5 Rest of the World (RoW)
14 Competitive Landscape (Page No. - 154)
14.1 Overview
14.2 Market Ranking
14.3 Competitive Situation and Trends
14.3.1 Agreements, Partnerships, and Collaborations
14.3.2 Approvals
15 Company Profiles (Page No. - 159)
(Overview, Products and Services, Financials, Strategy & Development)*
15.1 Introduction
15.2 Antares Pharma, Inc.
15.3 Endo International PLC
15.4 Pharmajet
15.5 Bioject Medical Technologies Inc. (Acquired By Inovio Pharmaceuticals, Inc.)
15.6 Medical International Technology, Inc. (MIT)
15.7 Injex Pharma AG
15.8 National Medical Products, Inc.
15.9 Valeritas, Inc.
15.10 European Pharma Group
15.11 Penject Corporation
15.12 Crossject
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.
16 Appendix (Page No. - 173)
16.1 Insight From Industry Experts
16.2 Discussion Guide
16.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
16.4 Introducing RT: Real-Time Market Intelligence
16.5 Available Customizations
16.6 Related Reports
16.7 Author Details
List of Tables (151 Tables)
Table 1 Indicative List of Products Approved in the U.S. Market
Table 2 Market Size, By Product, 2014-2021 (USD Million)
Table 3 Fillable Needle-Free Injectors Market Size, By Region, 2014-2021 (USD Million)
Table 4 Prefilled Needle-Free Injectors Market Size, By Region, 2014-2021 (USD Million)
Table 5 Market Size, By Technology, 2014–2021 (USD Million)
Table 6 Jet-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 7 Spring-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 8 Laser-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 9 Vibration-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 10 Market Size, By Type, 2014–2021 (USD Million)
Table 11 Liquid-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 12 Projectile/Depot-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 13 Powder-Based Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 14 Market Size, By Usability, 2014–2021 (USD Million)
Table 15 Disposable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 16 Reusable Needle-Free Injectors Market Size, By Region, 2014–2021 (USD Million)
Table 17 Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 18 Subcutaneous Injectors Market Size, By Region, 2014-2021 (USD Million)
Table 19 Intramuscular Injectors Market Size, By Region, 2014-2021 (USD Million)
Table 20 Intradermal Injectors Market Size, By Region, 2014-2021 (USD Million)
Table 21 Market Size, By Application, 2014-2021 (USD Million)
Table 22 Vaccine Delivery Market Size, By Region, 2014-2021 (USD Million)
Table 23 Insulin Delivery Market Size, By Region, 2014-2021 (USD Million)
Table 24 Oncology Market Size, By Region, 2014-2021 (USD Million)
Table 25 Pain Management Market Size, By Region, 2014-2021 (USD Million)
Table 26 Other Applications Market Size, By Region, 2014-2021 (USD Million)
Table 27 Market Size, By End User, 2014-2021 (USD Million)
Table 28 Hospitals and Clinics Market Size, By Region, 2014-2021 (USD Million)
Table 29 Home Care Settings Market Size, By Region, 2014-2021 (USD Million)
Table 30 Research Laboratories Market Size, By Region, 2014-2021 (USD Million)
Table 31 Pharmaceutical and Biotechnology Companies Market Size, By Region, 2014-2021 (USD Million)
Table 32 Other End Users Market Size, By Region, 2014-2021 (USD Million)
Table 33 Market Size, By Region, 2014–2021 (USD Million
Table 34 North America: Market Size, By Country, 2014-2021 (USD Million)
Table 35 North America: Market Size, By Product, 2014-2021 (USD Million)
Table 36 North America: Market Size, By Technology, 2014-2021 (USD Million)
Table 37 North America: Market Size, By Usability, 2014-2021 (USD Million)
Table 38 North America: Market Size, By Type, 2014-2021 (USD Million)
Table 39 North America: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 40 North America: Market Size, By Application, 2014-2021 (USD Million)
Table 41 North America: Market Size, By End User, 2014-2021 (USD Million)
Table 42 U.S.: Market Size, By Product, 2014-2021 (USD Million)
Table 43 U.S.: Market Size, By Technology, 2014-2021 (USD Million)
Table 44 U.S.: Market Size, By Usability, 2014-2021 (USD Million)
Table 45 U.S.: Market Size, By Type, 2014-2021 (USD Million)
Table 46 U.S.: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 47 U.S.: Market Size, By Application, 2014-2021 (USD Million)
Table 48 U.S.: Market Size, By End User, 2014-2021 (USD Million)
Table 49 Canada.: Market Size, By Product, 2014-2021 (USD Million)
Table 50 Canada: Market Size, By Technology, 2014-2021 (USD Million)
Table 51 Canada: Market Size, By Usability, 2014-2021 (USD Million)
Table 52 Canada: Market Size, By Type, 2014-2021 (USD Million)
Table 53 Canada: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 54 Canada: Market Size, By Application, 2014-2021 (USD Million)
Table 55 Canada: Market Size, By End User, 2014-2021 (USD Million)
Table 56 Europe: Market Size, By Country, 2014-2021 (USD Million)
Table 57 Europe: Market Size, By Product, 2014-2021 (USD Million)
Table 58 Europe: Market Size, By Technology, 2014-2021 (USD Million)
Table 59 Europe: Market Size, By Usability, 2014-2021 (USD Million)
Table 60 Europe Market Size, By Type, 2014-2021 (USD Million)
Table 61 Europe: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 62 Europe: Market Size, By Application, 2014-2021 (USD Million)
Table 63 Europe: Market Size, By End User, 2014-2021 (USD Million)
Table 64 Germany: Market Size, By Product, 2014-2021 (USD Million)
Table 65 Germany: Market Size, By Technology, 2014-2021 (USD Million)
Table 66 Germany: Market Size, By Usability, 2014-2021 (USD Million)
Table 67 Germany: Market Size, By Type, 2014-2021 (USD Million)
Table 68 Germany: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 69 Germany: Market Size, By Application, 2014-2021 (USD Million)
Table 70 Germany: Market Size, By End User, 2014-2021 (USD Million)
Table 71 France: Market Size, By Product, 2014-2021 (USD Million)
Table 72 France: Market Size, By Technology, 2014-2021 (USD Million)
Table 73 France: Market Size, By Usability, 2014-2021 (USD Million)
Table 74 France: Market Size, By Type, 2014-2021 (USD Million)
Table 75 France: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 76 France: Market Size, By Application, 2014-2021 (USD Million)
Table 77 France: Market Size, By End User, 2014-2021 (USD Million)
Table 78 U.K.: Market Size, By Product, 2014-2021 (USD Million)
Table 79 U.K.: Market Size, By Technology, 2014-2021 (USD Million)
Table 80 U.K.: Market Size, By Usability, 2014-2021 (USD Million)
Table 81 U.K.: Market Size, By Type, 2014-2021 (USD Million)
Table 82 U.K.: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 83 U.K.: Market Size, By Application, 2014-2021 (USD Million)
Table 84 U.K.: Market Size, By End User, 2014-2021 (USD Million)
Table 85 Italy: Market Size, By Product, 2014-2021 (USD Million)
Table 86 Italy: Market Size, By Technology, 2014-2021 (USD Million)
Table 87 Italy: Market Size, By Usability, 2014-2021 (USD Million)
Table 88 Italy: Market Size, By Type, 2014-2021 (USD Million)
Table 89 Italy: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 90 Italy: Market Size, By Application, 2014-2021 (USD Million)
Table 91 Italy: Market Size, By End User, 2014-2021 (USD Million)
Table 92 Spain: Market Size, By Product, 2014-2021 (USD Million)
Table 93 Spain: Market Size, By Technology, 2014-2021 (USD Million)
Table 94 Spain: Market Size, By Usability, 2014-2021 (USD Million)
Table 95 Spain: Market Size, By Type, 2014-2021 (USD Million)
Table 96 Spain: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 97 Spain: Market Size, By Application, 2014-2021 (USD Million)
Table 98 Spain: Market Size, By End User, 2014-2021 (USD Million)
Table 99 RoE: Market Size, By Product, 2014-2021 (USD Million)
Table 100 RoE: Market Size, By Technology, 2014-2021 (USD Million)
Table 101 RoE: Market Size, By Usability, 2014-2021 (USD Million)
Table 102 RoE: Market Size, By Type, 2014-2021 (USD Million)
Table 103 RoE: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 104 RoE: Market Size, By Application, 2014-2021 (USD Million)
Table 105 RoE: Market Size, By End User, 2014-2021 (USD Million)
Table 106 Asia: Market Size, By Country, 2014-2021 (USD Million)
Table 107 Asia: Market Size, By Product, 2014-2021 (USD Million)
Table 108 Asia: Market Size, By Technology, 2014-2021 (USD Million)
Table 109 Asia: Market Size, By Usability, 2014-2021 (USD Million)
Table 110 Asia: Market Size, By Type, 2014-2021 (USD Million)
Table 111 Asia: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 112 Asia: Market Size, By Application, 2014-2021 (USD Million)
Table 113 Asia: Market Size, By End User, 2014-2021 (USD Million)
Table 114 Japan: Market Size, By Product, 2014-2021 (USD Million)
Table 115 Japan: Market Size, By Technology, 2014-2021 (USD Million)
Table 116 Japan: Market Size, By Usability, 2014-2021 (USD Million)
Table 117 Japan: Market Size, By Type, 2014-2021 (USD Million)
Table 118 Japan: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 119 Japan: Market Size, By Application, 2014-2021 (USD Million)
Table 120 Japan: Market Size, By End User, 2014-2021 (USD Million)
Table 121 China: Market Size, By Product, 2014-2021 (USD Million)
Table 122 China: Market Size, By Technology, 2014-2021 (USD Million)
Table 123 China: Market Size, By Usability, 2014-2021 (USD Million)
Table 124 China: Market Size, By Type, 2014-2021 (USD Million)
Table 125 China: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 126 China: Market Size, By Application, 2014-2021 (USD Million)
Table 127 China: Market Size, By End User, 2014-2021 (USD Million)
Table 128 India: Market Size, By Product, 2014-2021 (USD Million)
Table 129 India: Market Size, By Technology, 2014-2021 (USD Million)
Table 130 India: Needle-Free Injection System Market Size, By Usability, 2014-2021 (USD Million)
Table 131 India: Market Size, By Type, 2014-2021 (USD Million)
Table 132 India: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 133 India: Market Size, By Application, 2014-2021 (USD Million)
Table 134 India: Market Size, By End User, 2014-2021 (USD Million)
Table 135 RoA: Needle-Free Injection System Market Size, By Product, 2014-2021 (USD Million)
Table 136 RoA: Market Size, By Technology, 2014-2021 (USD Million)
Table 137 RoA: Market Size, By Usability, 2014-2021 (USD Million)
Table 138 RoA: Market Size, By Type, 2014-2021 (USD Million)
Table 139 RoA: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 140 RoA: Market Size, By Application, 2014-2021 (USD Million)
Table 141 RoA: Market Size, By End User, 2014-2021 (USD Million)
Table 142 RoW: Needle-Free Injection System Market Size, By Product, 2014-2021 (USD Million)
Table 143 RoW: Market Size, By Technology, 2014-2021 (USD Million)
Table 144 RoW: Market Size, By Usability, 2014-2021 (USD Million)
Table 145 RoW: Market Size, By Type, 2014-2021 (USD Million)
Table 146 RoW: Market Size, By Site of Delivery, 2014-2021 (USD Million)
Table 147 RoW: Market Size, By Application, 2014-2021 (USD Million)
Table 148 RoW: Market Size, By End User, 2014-2021 (USD Million)
Table 149 Needle-Free Injection System Market Ranking, By Key Player, 2015
Table 150 Agreements, Partnerships, and Collaborations, 2013–2016
Table 151 Approvals, 2013–2016
List of Figures (33 Figures)
Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Jet-Based Needle-Free Injectors Market to Grow at the Highest Rate During the Forecast Period
Figure 7 Vaccine Delivery is Expected to Be the Fastest-Growing Application Segment During the Forecast Period
Figure 8 Intramuscular Injectors Market to Offer Significant Growth Opportunities
Figure 9 Hospitals and Clinics Segment to Grow at the Highest Rate in the End-User Market (2016-2021)
Figure 10 North America to Dominate the Market in 2016
Figure 11 Needle-Free Injection System Market to Offer Double-Digit Growth Rate During the Forecast Period
Figure 12 Liquid-Based Needle-Free Injectors to Grow at the Highest Rate (2016-2021)
Figure 13 Jet-Based Needle-Free Injectors to Hold the Largest Share of the Market in 2016
Figure 14 Hospitals and Clinics Segments to Witness Highest Growth in the Forecast Period
Figure 15 Germany to Witness Highest Growth During the Forecast Period
Figure 16 Needle-Free Injection System Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Prefilled Needle-Free Injectors Segment to Register Higher Growth During the Forecast Period
Figure 18 Jet-Based Needle-Free Injectors to Grow at the Highest CAGR During the Forecast Period
Figure 19 Liquid-Based Needle-Free Injectors to Witness Highest Growth During the Forecast Period
Figure 20 Disposable Needle-Free Injectors to Grow at the Highest Rate During the Forecast Period
Figure 21 Intramuscular Injectors to Witness Highest Growth During the Forecast Period
Figure 22 Vaccine Delivery Segment to Witness Highest Growth During the Forecast Period
Figure 23 Hospitals and Clinics to Hold Largest Market Share in 2016
Figure 24 North America:Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 Asia: Market Snapshot
Figure 27 RoW: Market Snapshot
Figure 28 Key Players Primarily Pursued Inorganic Growth Strategies Between 2013 and 2016
Figure 29 Battle for Market Share: Agreements, Partnerships, and Collaborations Was the Key Growth Strategy Adopted By Market Players
Figure 30 Geographic Mix for the Top Three Players in the Market
Figure 31 Company Snapshot: Antares Pharma, Inc.
Figure 32 Company Snapshot: Endo International PLC
Figure 33 Company Snapshot: Medical International Technology, Inc.
Get in-depth analysis of the COVID-19 impact on the Needle-Free Injection System Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Needle-Free Injection System Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Needle-Free Injection System Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Needle-Free Injection System Market